Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03937635 |
|---|---|
| Brief Title: | Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma |
| First Submitted : | April 24, 2019 |
| First Submitted that Met QC Criteria : | May 2, 2019 |
| First Posted : | May 6, 2019 |
| Last Update Submitted that Met QC Criteria : | July 7, 2020 |
| Last Update Posted : | July 8, 2020 |